Conclusion
Curcumin's diverse array of molecular targets affords it great potential as a therapeutic agent for a
variety of inflammatory conditions and cancer types.
Consequently, there is extensive interest in its therapeutic potential as evidenced by the number of ongoing phase II and III clinical trials. The primary obstacle to utilizing curcumin therapeutically has been its limited systemic bioavailability, but researchers are actively